MabCure Financials
| MBCI Stock | USD 0.0001 0.00 0.00% |
MabCure |
MabCure Stock Summary
MabCure competes with SMA Solar, Xinyi Solar, Xinyi Solar, Shoals Technologies, and Ascent Solar. MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. MabCure Inc. was founded in 2006 and is based in White Plains, New York. Mabcure is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 21 Sparrow Circle, |
| Sector | Technology |
| Industry | Solar |
| Benchmark | Dow Jones Industrial |
| Website | www.mabcure.com |
| Phone | 845 591 3144 |
| Currency | USD - US Dollar |
MabCure Key Financial Ratios
MabCure's financial ratios allow both analysts and investors to convert raw data from MabCure's financial statements into concise, actionable information that can be used to evaluate the performance of MabCure over time and compare it to other companies across industries.| Return On Equity | -1.25 | |||
| Return On Asset | -0.0422 | |||
| Beta | 0.0893 | |||
| Z Score | -5.4 |
MabCure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MabCure's current stock value. Our valuation model uses many indicators to compare MabCure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MabCure competition to find correlations between indicators driving MabCure's intrinsic value. More Info.MabCure is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value MabCure by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MabCure's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.MabCure Systematic Risk
MabCure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MabCure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on MabCure correlated with the market. If Beta is less than 0 MabCure generally moves in the opposite direction as compared to the market. If MabCure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MabCure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MabCure is generally in the same direction as the market. If Beta > 1 MabCure moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for MabCure Pink Sheet analysis
When running MabCure's price analysis, check to measure MabCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MabCure is operating at the current time. Most of MabCure's value examination focuses on studying past and present price action to predict the probability of MabCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MabCure's price. Additionally, you may evaluate how the addition of MabCure to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |